Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

3.34
Delayed Data
As of 3:26pm ET
 +0.03 / +0.91%
Today’s Change
1.03
Today|||52-Week Range
4.83
+29.46%
Year-to-Date
No recent news for Avadel Pharmaceuticals PLC.

Today’s Trading

Previous close3.31
Today’s open3.27
Day’s range3.25 - 3.47
Volume401,516
Average volume (3 months)296,026
Market cap$81.6M
Data as of 3:26pm ET, 09/19/2019

Growth & Valuation

Earnings growth (last year)-249.68%
Earnings growth (this year)+57.29%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)-40.94%
P/E ratioNM
Price/Sales0.93
Price/Book29.26

Competitors

 Today’s
change
Today’s
% change
--EcoGreen Internation...0.000.00%
SCPHscPharmaceuticals In...-0.34-5.16%
FBIOFortress Biotech Inc-0.13-7.18%
CORVCorrevio Pharma Corp-0.05-2.06%
Data as of 3:43pm ET, 09/19/2019

Financials

Next reporting dateNovember 5, 2019
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$103.2M
Annual profit (last year)-$95.2M
Net profit margin-92.29%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Gregory J. Divis
Senior VP, Chief Financial &
Accounting Officer
Michael F. Kanan
Corporate headquarters
Dublin, Dublin

Forecasts